Retroviral vectors elevate coexpressed protein levels in trans through cap-dependent translation

Proceedings of the National Academy of Sciences of the United States of America
Yongqiang GouJaquelin P Dudley

Abstract

Retroviruses cause immunodeficiency and cancer but also are used as vectors for the expression of heterologous genes. Nevertheless, optimal translation of introduced genes often is not achieved. Here we show that transfection into mammalian cells of lentiviral or gammaretroviral vectors, including those with specific shRNAs, increased expression of a cotransfected gene relative to standard plasmid vectors. Levels of most endogenous cellular proteins were unchanged. Transfer of lentiviral vector sequences into a standard plasmid conferred the ability to give increased expression of cotransfected genes (superinduction). Superinduction by the retroviral vector was not dependent on the cell type or species, the type of reporter gene, or the method of transfection. No differences were detected in the IFN, unfolded protein, or stress responses in the presence of retroviral vectors. RT-PCRs revealed that RNA levels of cotransfected genes were unchanged during superinduction, yet Western blotting, pulse labeling, and the use of bicistronic vectors showed increased cap-dependent translation of cointroduced genes. Expression of the mammalian target of rapamycin (mTOR) kinase target 4E-BP1, but not the mTOR inhibitor Torin 1, preferential...Continue Reading

References

Jun 11, 1999·Genes & Development·A C GingrasN Sonenberg
Oct 26, 2005·Biochemical Society Transactions·P SarnowE Jan
Nov 12, 2005·Journal of Virology·Jennifer A MertzJaquelin P Dudley
Feb 18, 2006·Molecular Cell·Christian P PetersenPhillip A Sharp
Nov 17, 2007·Cell Host & Microbe·James P WhiteRichard E Lloyd
Jul 28, 2009·The Journal of Biological Chemistry·Jennifer A MertzJaquelin P Dudley
Jun 23, 2010·Proceedings of the National Academy of Sciences of the United States of America·Hyewon ByunJaquelin P Dudley
Nov 11, 2011·Journal of Virology·Hyewon ByunJaquelin P Dudley
May 3, 2012·Cold Spring Harbor Perspectives in Biology·Daniel N Wilson, Jamie H Doudna Cate
May 4, 2012·Nature·Carson C ThoreenDavid M Sabatini
Jul 12, 2012·Frontiers in Microbiology·Hisatoshi Shida
Jan 29, 2013·Cellular and Molecular Life Sciences : CMLS·Neysan DonnellyAfshin Samali
Jul 19, 2013·Biochemical Society Transactions·Carson C Thoreen
Aug 1, 2013·Proceedings of the National Academy of Sciences of the United States of America·Kateryna FeoktistovaChristopher S Fraser
Dec 12, 2013·Journal of Molecular Biology·Arjun Rustagi, Michael Gale
Feb 4, 2014·Molecular Immunology·Mathieu GigouxWoong-Kyung Suh
Aug 8, 2014·Frontiers in Immunology·Stephanie ReikineYorgo Modis
Aug 15, 2014·Nature·Delphine GoubauCaetano Reis e Sousa
Aug 28, 2014·Frontiers in Immunology·Ryan McClure, Paola Massari

❮ Previous
Next ❯

Citations

Jun 3, 2017·Cold Spring Harbor Perspectives in Biology·Rudolf E LeubeReinhard Windoffer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.